4,542
edits
Changes
Jump to navigation
Jump to search
Line 1:
Line 1: − + − Line 7:
Line 6: − + − '''Sources:''' <references/>
no edit summary
The HPV vaccine protects against some strains of the human papillomavirus (HPV), which are sexually transmitted diseases. HPV is the primary cause of cervical cancer and may also play a role in the development of other types of cancer [http://www.cancer.gov/cancertopics/factsheet/Risk/HPV
The HPV vaccine protects against some strains of the human papillomavirus (HPV), which are sexually transmitted diseases. HPV is the primary cause of cervical cancer and may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. Food and Drug Administration approved the first HPV vaccine based on observance of elevated [[antibody]] levels in a few thousand patients who had received the vaccine (including perhaps only a few hundred or less young girls).
]. In June 2006, the U.S. Food and Drug Administration approved the first HPV vaccine based on observance of elevated [[antibody]] levels in a few thousand patients who had received the vaccine (including perhaps only a few hundred or less young girls).
Merck manufactures the HPV vaccine and sells it for $360 ($120 per shot in a three-shot series). Its package insert explains the limitations of the vaccine and describes its testing for safety and efficacy.<ref>http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf</ref>
Merck manufactures the HPV vaccine and sells it for $360 ($120 per shot in a three-shot series). Its package insert explains the limitations of the vaccine and describes its testing for safety and efficacy.<ref>http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf</ref>
----
----
<references/>